Western blot analysis of 17 breast cancer cell lines showed higher protein expression of GLS and TYMS in TNBC cell lines compared to ER+ and HER2-amplified cell lines, and higher expression ALDH18A and PYCR2 in TNBC compared with ER+ cell lines. This evidence concerns the gene GLS and breast carcinoma.